Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer.
about
Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Standing the test of time in E ...... of non-small-cell lung cancer.
@en
Standing the test of time in E ...... of non-small-cell lung cancer.
@nl
type
label
Standing the test of time in E ...... of non-small-cell lung cancer.
@en
Standing the test of time in E ...... of non-small-cell lung cancer.
@nl
prefLabel
Standing the test of time in E ...... of non-small-cell lung cancer.
@en
Standing the test of time in E ...... of non-small-cell lung cancer.
@nl
P2860
P356
P1476
Standing the test of time in E ...... of non-small-cell lung cancer.
@en
P2093
Sarah J Danson
P2860
P356
10.2147/LCTT.S9974
P577
2010-05-12T00:00:00Z